Hyperinflation
8
2
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Secondhand Smoke Respiratory Health Study
Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
4D Medical X-ray Velocimetry for Bronchoscopic Lung Volume Reduction Targeting
Bronchial Thermoplasty for Severe Asthma With Dynamic Hyperinflation
Electrical Impedance Imaging of Patients on Mechanical Ventilation
Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients
Device-guided Breathing for Shortness of Breath in COPD